Dmitry Balyasny’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-2,257,912
| Closed | -$298M | – | 3505 |
|
|
2025
Q1 | $298M | Buy |
2,257,912
+2,118,252
| +1,517% | +$264M | 0.49% | 27 |
|
|
2024
Q4 | $11.7M | Buy |
+139,660
| New | +$11.5M | 0.02% | 896 |
|
|
2024
Q3 | – | Sell |
-406,714
| Closed | -$27.9M | – | 3255 |
|
|
2024
Q2 | $27.9M | Sell |
406,714
-3,920
| -1% | -$272K | 0.05% | 488 |
|
|
2024
Q1 | $28.4M | Buy |
410,634
+100,641
| +32% | +$6.92M | 0.05% | 490 |
|
|
2023
Q4 | $22.2M | Buy |
+309,993
| New | +$17.8M | 0.04% | 557 |
|
|
2023
Q3 | – | Sell |
-130,607
| Closed | -$8.27M | – | 2821 |
|
|
2023
Q2 | $8.27M | Buy |
130,607
+123,282
| +1,683% | +$7.68M | 0.02% | 860 |
|
|
2023
Q1 | $397K | Buy |
7,325
+6,657
| +997% | +$322K | ﹤0.01% | 2016 |
|
|
2022
Q4 | $35.4K | Sell |
668
-4,640
| -87% | -$233K | ﹤0.01% | 2402 |
|
|
2022
Q3 | $247K | Buy |
+5,308
| New | +$277K | ﹤0.01% | 2258 |
|
|
2022
Q2 | – | Sell |
-31,967
| Closed | -$1.96M | – | 3272 |
|
|
2022
Q1 | $1.96M | Buy |
+31,967
| New | +$1.66M | 0.01% | 1379 |
|
|
2018
Q4 | – | Sell |
-508,750
| Closed | -$11M | – | 1833 |
|
|
2018
Q3 | $11M | Buy |
508,750
+50,859
| +11% | +$1.06M | 0.05% | 456 |
|
|
2018
Q2 | $8.09M | Buy |
457,891
+55,765
| +14% | +$1.13M | 0.04% | 544 |
|
|
2018
Q1 | $8.46M | Buy |
402,126
+291,973
| +265% | +$5.69M | 0.04% | 572 |
|
|
2017
Q4 | $1.59M | Sell |
110,153
-29,200
| -21% | -$451K | 0.01% | 1207 |
|
|
2017
Q3 | $2.2M | Buy |
+139,353
| New | +$2.04M | 0.01% | 929 |
|
|
2016
Q2 | – | Sell |
-55,100
| Closed | -$1.53M | – | 1500 |
|
|
2016
Q1 | $1.53M | Buy |
55,100
+45,730
| +488% | +$1.52M | 0.01% | 731 |
|
|
2015
Q4 | $504K | Buy |
+9,370
| New | +$473K | ﹤0.01% | 828 |
|
|
2015
Q3 | – | Sell |
-50,000
| Closed | -$1.63M | – | 1431 |
|
|
2015
Q2 | $1.6M | Buy |
+50,000
| New | +$1.27M | 0.01% | 762 |
|
Other funds holding ITCI
KIM
HNB
Dmitry Balyasny's ITCI Position: Q2 2025 in Review
Dmitry Balyasny sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2025, closing a stake of 2,257,912 shares — an estimated $298M sold.
Dmitry Balyasny first reported a position in ITCI in Q2 2015 and held it in 18 quarters. The position peaked at $298M in Q1 2025. 4 funds tracked by Wall St. Rank hold ITCI as of Q2 2025.
- Dmitry Balyasny reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2025 after selling out during the quarter.
- Dmitry Balyasny sold 2,257,912 Intra-Cellular Therapies Inc. shares in Q2 2025, an estimated $298M.
- Dmitry Balyasny first reported a position in Intra-Cellular Therapies Inc. in Q2 2015 and held it in 18 quarters.
- Dmitry Balyasny's Intra-Cellular Therapies Inc. position peaked at $298M in Q1 2025.
- 4 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2025.
Based on Balyasny Asset Management's 13F filing for Q2 2025, filed 14 Aug 2025.